Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.49 is 85% above its 5-year average of -3.33, near the high end of its 5-year range (-4.37–-0.49).
82.44% above its 12-month average of -2.79.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.37.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 38 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.49
EARNINGS PER SHARE (EPS) AVG TTM
-2.79
EARNINGS PER SHARE (EPS) AVG 3Y
-3.24
EARNINGS PER SHARE (EPS) AVG 5Y
-3.33
EARNINGS PER SHARE (EPS) AVG 10Y
-2.39
EARNINGS PER SHARE (EPS) AVG 15Y
-2.69
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+82.44%
CURRENT VS 3Y AVG
+84.88%
CURRENT VS 5Y AVG
+85.29%
CURRENT VS 10Y AVG
+79.50%
CURRENT VS 15Y AVG
+81.80%
CURRENT VS 20Y AVG
N/A
Travere Therapeutics, Inc.
Market Cap
$5.21B
Earnings Per Share (EPS)
-0.49
TTM Avg
-2.79
3Y Avg
-3.24
5Y Avg
-3.33
Market Cap
$5.20B
Earnings Per Share (EPS)
0.57
TTM Avg
0.22
3Y Avg
-0.05
5Y Avg
0.01
Market Cap
$5.21B
Earnings Per Share (EPS)
-4.76
TTM Avg
-5.40
3Y Avg
-5.28
5Y Avg
-3.57
Market Cap
$5.20B
Earnings Per Share (EPS)
0.85
TTM Avg
1.12
3Y Avg
0.90
5Y Avg
0.76
Market Cap
$5.19B
Earnings Per Share (EPS)
-2.31
TTM Avg
-2.18
3Y Avg
-2.26
5Y Avg
-2.81
Market Cap
$5.32B
Earnings Per Share (EPS)
-0.58
TTM Avg
1.92
3Y Avg
-3.08
5Y Avg
-4.40
Market Cap
$5.09B
Earnings Per Share (EPS)
-3.31
TTM Avg
-2.88
3Y Avg
-2.49
5Y Avg
-2.72
Market Cap
$5.07B
Earnings Per Share (EPS)
2.42
TTM Avg
2.12
3Y Avg
1.80
5Y Avg
1.31
Market Cap
$5.06B
Earnings Per Share (EPS)
0.70
TTM Avg
0.25
3Y Avg
-0.03
5Y Avg
-0.08
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | $5.21B | -0.49 | -2.79 | -3.24 | -3.33 |
| Sotera Health Company (SHC)vs › | $5.20B | 0.57 | 0.22 | -0.05 | 0.01 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | -4.76 | -5.40 | -5.28 | -3.57 |
| Doximity, Inc. (DOCS)vs › | $5.20B | 0.85 | 1.12 | 0.90 | 0.76 |
| Cogent Biosciences, Inc. (COGT)vs › | $5.19B | -2.31 | -2.18 | -2.26 | -2.81 |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | -0.58 | 1.92 | -3.08 | -4.40 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.09B | -3.31 | -2.88 | -2.49 | -2.72 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 2.42 | 2.12 | 1.80 | 1.31 |
| Waystar Holding Corp. (WAY)vs › | $5.06B | 0.70 | 0.25 | -0.03 | -0.08 |
| Erasca, Inc. (ERAS)vs › | $4.96B | -0.95 | -0.56 | -0.99 | -0.97 |
Trailing EPS (TTM)
$-0.49
Forward EPS (Est.)
$-0.03
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2024-12-31 | -4.08 |
| 2023-12-31 | -1.50 |
| 2022-12-31 | -4.37 |
| 2021-12-31 | -3.01 |
| 2020-12-31 | -3.56 |
| 2019-12-31 | -3.46 |
| 2018-12-31 | -2.54 |
| 2017-12-31 | -1.54 |
| 2016-12-31 | -1.29 |
| 2015-12-31 | 3.49 |
| 2014-12-31 | -4.43 |
| 2013-12-31 | -2.38 |
| 2012-02-29 | -0.14 |
| 2009-02-28 | 0.00 |
